Neurocrine Biosciences Inc (NBIX)

NASDAQ · Biotechnology

156.74
+2.71 (+1.76%)
Updated Sep 1, 7:57 PM ET
AI Rating
Hold
Overall Score
59
Trend
57
Momentum
44
Risk
85

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

Neurocrine Biosciences Inc is trading at $156.74, up 1.76% on the session. The 50 day average sits at $166.45 and the 200 day at $147.26, which puts the stock in a uptrend. RSI is at 40.5, which reads as weak, and MACD is bullish crossover. Volume is below average.

The nearest support is around $151.77 with resistance near $156.56, so that band frames the current range. Average daily movement is roughly $4.61, or about 2.9% of the share price, which is what any stop placement has to allow for. The overall health score of 59 out of 100 combines a trend score of 57, momentum of 44 and a risk score of 85.

Technical indicators

RSI (14)
40.5
weak
MACD
-3.836
bullish crossover
SMA 20
157.33
SMA 50
166.45
SMA 200
147.26
uptrend
ATR (14)
4.61
avg daily range
Support
151.77
Resistance
156.56
Volume vs 20d
0.59x
below average
Volatility
26.5%
annualised
1 month
-16.95%
3 months
-2.68%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.